Latest

Kromek presenting at European Photonics 2019

02/04/2019

Kromek at the European Photonics Roadshow 2019

The European Photonics Roadshow 2019 event will be at two locations:

  • 3 April 2019
    Baltic Centre for Contemporary Art
    9.00 am to 9.30 pm
    South Shore Rd, Gateshead, NE8 3BA.
  • 4 April 2019
    The Core
    8.30 am to 1.15 pm
    Bath Lane, Newcastle Helix, Newcastle, NE4 5TF

The European Photonics Roadshow 2019 is an opportunity to meet photonic companies and learn from experts in MedTech and pharmaceuticals, and to explore new business leads and potential collaborations. At this two day event, you will hear from a panel of international experts, who will cover a range of healthcare market, innovation, investment and photonics topics.

Event website: https://photonics-roadshow-newcastle.b2match.io/

One of the experts you will hear from is Kromek’s Bartosz Balczerski, PhD.

Bartek is one of our Principal Investigator that specialises in our work in molecular breast imaging (MBI).

Breast cancer is the most common cancer in women. About 1 in 8 women in the UK are diagnosed with breast cancer during their lifetime. Mammography, the backbone of NHS’s breast cancer screening programme, suffers from high false positives (25%) and false negatives (15%). MBI system makes use of a pair of cadmium zinc telluride (CZT) digital SPECT detectors with specialized collimators to improve sensitivity and specificity in breast cancer detection.

Bartek will be talking about Kromek’s CZT (cadmium zinc telluride) medical camera technology particularly about our CZT 3D MBI and low dose MBI work.

Kromek has two projects currently running that are designed to help detect breast cancer:

  1. 3D MBI
    Kromek is working in collaboration with DTU Space at the Technical University of Denmark (DTU) to develop new detector electronics and geometry for use with Kromek’s cadmium zinc telluride (CZT) crystals. https://www.kromek.com/user-stories/from-space-scanners-to-cancer-scanners/
  2. Low Dose MBI
    Kromek has been awarded funding from the UK’s Innovation agency, Innovate UK, for a three-year programme to deliver, in partnership with one of the country’s few ‘Outstanding’ NHS Trusts, Newcastle-upon-Tyne Hospitals NHS Foundation Trust (Newcastle Hospitals), a low dose molecular breast imaging (LDMBI) technology based on Kromek’s CZT-based SPECT detectors. https://www.kromek.com/news/ldmbi-contract/

 

We’re looking for clinical, diagnostic and pharmaceutical partners with challenges in their respective fields where a new generation of photonics will lead to new healthcare solutions.

See Bartek’s CZT MBI presentation

If you are unable to make the event but want to learn more about Kromek work please complete this form and we will send you the presentation after the event.

Enquiry Form

 

 

  Back to Latest

Related articles

Stay up to date with Kromek news

Join our mailing list

Unsure what product you need?